info@marketresearchfuture.com   ­čô×  +1 (855) 661-4441(US)   ­čô×  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players├óÔéČÔäó financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Psoriasis Treatment Companies

Psoriasis is a chronic autoimmune skin condition, and several companies are dedicated to the research, development, and commercialization of treatments for psoriasis. These treatments may include topical medications, oral medications, biologics, and other therapies aimed at managing symptoms and improving the quality of life for individuals with psoriasis.

Psoriasis Treatment Key Companies

 

Latest Psoriasis Treatment Companies Update


Nov 2023AbbVie (US) Reported positive top-line results from a Phase 3 study of their JAK inhibitor Skyrizi® (risankizumab) for improving skin clearance and joint health in patients with moderate-to-severe psoriatic arthritis.Launched online patient support programs and educational resources to empower individuals with psoriasis to manage their condition effectively.


Eli Lilly and Company (US) Received FDA approval for their IL-23 inhibitor Taltz® (ixekizumab) for the treatment of moderate-to-severe plaque psoriasis in adults.Collaborated with dermatology societies and clinics to expand access to their psoriasis treatment options and improve patient care.


Johnson & Johnson (US) Announced positive results from a Phase 2b study of their IL-17A inhibitor Tremfya® (guselkumab) for the treatment of palmoplantar pustulosis, a rare and challenging form of psoriasis.Partnered with patient advocacy groups to raise awareness about different psoriasis types and promote early diagnosis and treatment.


Novartis International AG (Switzerland) Launched their Cosentyx® (secukinumab) in new markets for the treatment of plaque psoriasis and other forms of the condition.Focused on developing next-generation biologics with longer dosing intervals and improved efficacy for optimal disease control.


LEO Pharma A/S (Denmark) Introduced their Enstilar® (calcipotriol) foam as a convenient and effective topical treatment option for mild-to-moderate plaque psoriasis.Invested in research on novel topical formulations and combination therapies for improving treatment outcomes and patient satisfaction.


List of Psoriasis Treatment Key Companies in the Market



  • Johnson & Johnson Services, Inc. (US)

  • Pfizer Inc. (US)

  • LEO Pharma A/S (Denmark)

  • Novartis AG (Switzerland)

  • Merck & Co., Inc. (US)

  • UCB S.A. (Belgium)

  • AbbVie Inc. (US)

  • Sun Pharmaceutical Industries Ltd. (India)

  • Eli Lilly and Company (US)

  • Amgen Inc. (US)

  • Evelo Biosciences, Inc. (US)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.